[Advanced GIST: Which treatments in 2022?]

Abstract excerpt

Gastrointestinal stromal tumors (GIST) are rare digestive tumors. Activating KIT mutations are the most common molecular alteration in these patients, identified in approximately 70 % of cases, followed by PDGFRA mutations (10-15 %), of which the D842V mutation accounts for most cases. Succinate dehydrogenase (SDH) deficiency and alterations involving NF1, BRAFV600E, RAS or NTRK genes are rare molecular...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Electron Transport Complex II
• Share to Gastrointestinal Neoplasms
• Share to Gastrointestinal Stromal Tumors